30 Chemistry "University of Glasgow" positions at University of Liverpool in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
An exciting opportunity has a risen within the E.P.S.R.C. Centre of Doctoral Training (CDT) in Digital and Automated Materials Chemistry to support the effective operation of the centre. The goal
-
by UKRI under the Frontier Research Guarantee scheme. The project aims at developing single-molecule optoelectronic devices, leveraging the opportunities given by synthetic chemistry into the wider
-
platforms. You will have a key role in developing automated methodologies for polymer chemistry and will work closely with roboticists and engineers in the Cooper group and other collaborators. The aim is to
-
computer codes to solve some of the daily research problems and have experience with high performance computing. You should have a PhD in Chemistry, Physics or Materials Science with a proven research track
-
A Postdoctoral Research Associate (PDRA) position is available immediately in the department of Chemistry, as part of the research groups of Professor Andrew Cooper FRS and Professor Anna Slater. We
-
large consortium of academic and industrial partners. AIChemy has was funded to promote the development of novel AI methods and to transform the uptake of AI in the chemistry community. The consortium
-
multidisciplinary team to electrochemically characterise new cathodes for lithium-ion batteries. You should have a PhD in chemistry or materials science and a track record of electrochemical or battery research
-
An exciting opportunity has a risen within the E.P.S.R.C. Centre of Doctoral Training (CDT) in Digital and Automated Materials Chemistry to support the effective operation of the centre. The goal
-
of automation and robotics platforms. The activity is in collaboration with University of Glasgow (biological models) and the University of Strathclyde (mechanobiology actuation). The post is available from 1
-
, University of Glasgow, University of Liverpool and University of Manchester) and four industry partners (GSK, AstraZeneca, Optum and Hammersmith Medicines Research) will provide a unique powerfully synergistic